Clinical Highlights From the American Diabetes Association’s Scientific Sessions
Listen now
Description
Endocrinologist Robert Gabbay, MD, PhD, the ADA’s chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss medications, “game-changing” diabetes technologies, and a new use for a familiar drug.
Related Content:
New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA’s Scientific Sessions
More Episodes
Extreme heat and its health outcomes are becoming more common. Jeremy Hess, MD, MPH, an emergency medicine physician and professor at the University of Washington, and Andrew Phelps, former director of the Oregon Department of Emergency Management, join Jennifer Abbasi, director of JAMA Medical...
Published 09/06/24
Here’s What to Know About the New Mpox Global Emergency; Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes
Related Content:
As Mpox Cases Surge in Africa, WHO Declares a Global Emergency—Here’s What to Know Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes...
Published 08/30/24
Published 08/30/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
